F

Fresenius Medical Care

Operates dialysis facilities and renal care

Head of Commercial Marketing and Customer Experience

Full-TimeUpdated on 10/23/2026Deadline 10/31/26
No salary listed
Expert
Bachelor's, MBA
Heilbronn, Germany+1 moreMore locations: Krems an der Donau, Austria
HybridInternational travel of approximately 30–50%.
Growth & MarketingProduct Marketing

About the job

Requirements
  • A completed degree, for example in biomedical engineering or business, or an equivalent qualification; alternatively, training as a cardiac perfusionist or registered nurse. An MBA is advantageous.
  • At least 10 years of experience in international downstream commercial marketing, ideally in medical technology, critical care, or complex capital equipment.
  • Three to five years of leadership experience and a willingness to develop and inspire international teams, particularly Clinical Application Specialists or Customer Success Managers.
  • Successful experience launching complex medical therapies globally and developing and implementing go-to-market strategies.
  • Strong knowledge of intensive care medicine, ventilation, and ECLS/ECMO; experience in SCS or organ support is advantageous.
  • Extensive experience collaborating with Sales, Product Management, R&D, and Marketing Communications, and managing matrix organizations.
  • Strategic and entrepreneurial thinking, a hands-on approach, and strong execution skills.
  • Strong communication, facilitation, and presentation skills, with a persuasive and motivating manner.
  • A strong customer orientation and interest in innovative medical technologies and therapy concepts.
  • Intercultural competence, ability to work in teams, and openness to change in an international environment.
  • Very good written and spoken German and English.
  • Proficiency with Microsoft 365, Teams, SharePoint, and modern digital communication and marketing tools.
  • Willingness to travel internationally approximately 30–50% of the time.
Responsibilities
  • Develop and manage global go-to-market strategies for the Heart & Lung portfolio and strategic therapy innovations, translating them into value propositions, clinical messaging, and commercial measures.
  • Lead international commercial positioning of the product portfolio, analyze market and competitor trends, and identify growth and market-entry opportunities.
  • Drive international launches of new therapies, particularly SCS, and work with Sales on clinical use, user training, and sustained therapy adoption.
  • Lead an international team of Clinical Application Specialists, set clear goals, and establish standards for high-quality clinical customer support.
  • Oversee the development and execution of global marketing campaigns, sales-enablement materials, digital content, and international trade-fair and congress appearances.
  • Shape the global customer journey from clinical studies and product demonstrations through procurement and onboarding to long-term therapy and account development.
  • Support an international network of Key Opinion Leaders and strategic partners to strengthen clinical evidence, peer-to-peer education, and international therapy adoption.
  • Establish structured feedback processes with customers and field teams, and translate market and customer needs into input for product management, innovation, and future R&D roadmaps.
  • Collaborate closely with Global Sales, Product Management, R&D, and Marketing Communications to align strategy and execution.
  • Ensure compliance with relevant legal, regulatory, and internal requirements and promote a consistently patient-oriented approach.
Desired Qualifications
  • An MBA is advantageous.
  • Experience in medical technology, critical care, or complex capital equipment is ideal.
  • Experience in SCS or organ support is advantageous.

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...